Clinuvel Pharmaceuticals Ltd. Sponsored ADR (CLVLY)
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2026 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2026 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (CLVLY) Q4 2025 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (OTCPK:CLVLY) Q4 2025 Earnings Conference Call August 28, 2025 4:00 AM ET Company Participants Malcolm Bull - Head of Australian Operations & Investor Relations Peter Vaughan - Chief Financial Officer Philippe Jacques Wolgen - MD & Director Conference Call Participants David Andrew Stanton - Jefferies LLC, Research Division Mark Pachacz - Unidentified Company Melissa Benson - Barrenjoey Markets Pty Limited, Research Division Shane A. Storey - Wilsons Advisory and Stockbroking Limited, Research Division Sinclair Currie - MA Moelis Australia Securities, Research Division Thomas Wakim - Bell Potter Securities Limited, Research Division Stella Mariss - Unidentified Company Stella Mariss Hello, everyone.
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2025 Earnings Call Transcript
Clinuvel Pharmaceuticals Limited (OTCPK:CLVLY) Q2 2025 Results Conference Call February 27, 2025 2:00 AM ET Company Participants Stella Mariss - Monsoon Communications Malcolm Bull - Head of IR Peter Vaughan - Company Secretary and CFO Lachlan Hay - Chief Operations Officer Philippe Wolgen - Chief Executive Officer Stella Mariss Hello, everyone. Thank you for joining CLINUVEL's Investor webinar today.
